The few reports of HCMV-specific IL-10 CD8+ T cell or regulatory responses have been in patients with other infections such as HIV [61] and HBV [42], or in liver transplant patients who have progressed to CMV disease [41], or in ageing studies using a pp65-specific tetramer [62]. This evidence concerns the gene CD8A and glycogen storage disease VI.